Adaptimmune Therapeutics shares owned by Commonwealth Equity Services
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Commonwealth Equity Services
from 13F filings
Historical chart of Commonwealth Equity Services investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Commonwealth Equity Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $26k | 16k | 1.59 |
| 2023-12-31 | $13k | 17k | 0.78 |
| 2023-09-30 | $25k | 32k | 0.78 |
| 2023-06-30 | $29k | 32k | 0.91 |
| 2020-06-30 | $285k | 29k | 10.00 |